Psyence BiomedicalPBM
13F holders, Q1 2026 (March 31)2holders +1
1new positions
0sold out
$3.80avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Psyence Biomedical Ltd. (PBM) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($575K) and Stonehage Fleming Financial Services Holdings Ltd ($218).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F407
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $218 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 89 shares bought, net +89 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Parallel Advisors, LLC | 0.01% | No change | 151,250 | $575K |
| Stonehage Fleming Financial Services Holdings Ltd | 0.00% | New | 89 | $218 |
"% of holder's portfolio" is PBM's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.